Luye Pharma Announces Innovative Drug - Risperidone Extended Release Microspheres for Injection has Reached Final Stage of NDA Process

SHANGHAI, Dec. 30, 2018 /PRNewswire/ -- Luye Pharma Group, an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications, today announced that it has entered the final stage of New Drug Application (NDA) submissions for the innovative drug, ...

from PR Newswire: http://bit.ly/2RvJjQ1